Spots Global Cancer Trial Database for meningioma
Every month we try and update this database with for meningioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Peptide Receptor Radionuclide Therapy Administered to Participants With Meningioma With 67Cu-SARTATE™ | NCT03936426 | Meningioma | Cu-64 SARTATE a... | 50 Years - | Clarity Pharmaceuticals Ltd | |
| Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma: | NCT06036706 | Meningioma Radiation Toxic... | Normo-fractiona... Hypo-fractionat... Normo-fractiona... Cognitive asses... | 20 Years - 65 Years | Centre Francois Baclesse | |
| Cognitive Status After Removal of Skull Base Meningioma | NCT04635657 | Meningioma Skull Base Meni... Frontal Meningi... Temporal Mening... Cognitive Impai... Cognitive Decli... Post-Surgical C... | Long-term Cogni... | 18 Years - 89 Years | Ohio State University | |
| Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2) | NCT04374305 | Neurofibromatos... Vestibular Schw... Non-vestibular ... Meningioma Ependymoma | Brigatinib Neratinib | 12 Years - | Massachusetts General Hospital | |
| Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma | NCT03971461 | Meningioma | Lutathera | 18 Years - | NYU Langone Health | |
| Research of Biomarkers of Response to Proton Beam Therapy in Pediatric and Adult Patients. | NCT04367779 | Brain Cancer Meningioma Sarcoma | - | Centre Leon Berard | ||
| 68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors | NCT03001349 | Meningioma Metastatic Well... Multiple Endocr... Neuroendocrine ... Somatostatin Po... Von Hippel-Lind... | Computed Tomogr... Gallium Ga 68-E... Positron Emissi... | - | M.D. Anderson Cancer Center | |
| The Etiology and Progression of Brain Tumors | NCT01811524 | Brain Tumor Glioma Meningioma | 1 Month - 85 Years | Tampere University Hospital | ||
| Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma | NCT02282917 | Vestibular Schw... Meningioma Acoustic Neurom... Neurofibromatos... | AR-42 | 18 Years - | Massachusetts Eye and Ear Infirmary | |
| A Study of ONC201 for Refractory Meningioma | NCT06012929 | Meningioma Refractory Meni... Relapsed Mening... | ONC201 | 19 Years - | University of Nebraska | |
| A Study of ONC201 for Refractory Meningioma | NCT06012929 | Meningioma Refractory Meni... Relapsed Mening... | ONC201 | 19 Years - | University of Nebraska | |
| Proton Radiation For Meningiomas and Hemangiopericytomas | NCT01117844 | Meningioma Hemangiopericyt... | Proton Radiatio... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| PREselection of Patients at Risk for COgnitive DEcline After Radiotherapy Using Advanced MRI | NCT04638478 | Meningioma | PRECODE-MRI | 18 Years - | Maastricht Radiation Oncology | |
| Cabozantinib for Patients With Recurrent or Progressive Meningioma | NCT05425004 | Meningioma | Cabozantinib | 18 Years - | Baptist Health South Florida | |
| Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System | NCT04743310 | Central Nervous... | tozuleristide Canvas imaging ... Surgical resect... | 18 Years - | Cedars-Sinai Medical Center | |
| Peptide Receptor Radionuclide Therapy Administered to Participants With Meningioma With 67Cu-SARTATE™ | NCT03936426 | Meningioma | Cu-64 SARTATE a... | 50 Years - | Clarity Pharmaceuticals Ltd | |
| Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors | NCT03220646 | Brain Tumor | abemaciclib abemaciclib | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| 68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors | NCT03001349 | Meningioma Metastatic Well... Multiple Endocr... Neuroendocrine ... Somatostatin Po... Von Hippel-Lind... | Computed Tomogr... Gallium Ga 68-E... Positron Emissi... | - | M.D. Anderson Cancer Center | |
| Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE | NCT06377371 | Meningioma | Brain Imaging w... Radio-guided Su... | 18 Years - 99 Years | Weill Medical College of Cornell University | |
| Fluorescence Guided Resection of Brain Tumors | NCT00870779 | Brain Tumors | 5-aminolevulini... | 21 Years - | Dartmouth-Hitchcock Medical Center | |
| Abemaciclib in Newly Diagnosed Meningioma Patients | NCT05940493 | Meningioma | Abemaciclib Placebo | 18 Years - | St. Joseph's Hospital and Medical Center, Phoenix | |
| Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients | NCT00985036 | Glioma Meningioma | Blood test | - | Marquette General Health System | |
| Proton Dose Escalation for Patients With Atypical or Anaplastic Meningiomas | NCT02978677 | Meningioma | Radiotherapy 68... Radiotherapy 72... Radiotherapy 60... | 18 Years - | Technische Universität Dresden | |
| Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients | NCT00985036 | Glioma Meningioma | Blood test | - | Marquette General Health System | |
| Gallium Ga 68-DOTATATE PET/CT in Predicting Tumor Growth in Patients With Meningiomas | NCT03953131 | Meningioma | Computed Tomogr... Gallium Ga 68-D... Positron Emissi... | 18 Years - | M.D. Anderson Cancer Center | |
| Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE | NCT06377371 | Meningioma | Brain Imaging w... Radio-guided Su... | 18 Years - 99 Years | Weill Medical College of Cornell University | |
| Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical Trial | NCT06126588 | Meningioma | Everolimus | 18 Years - 80 Years | Central Hospital, Nancy, France | |
| AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas | NCT02831257 | Neurofibromatos... Meningioma | AZD2014 | 18 Years - | Massachusetts General Hospital | |
| Intravenous Tranexamic Acid Reducing Intraoperative Blood Loss in Huge Meningiomas Resection | NCT05230381 | Tranexamic Acid Intraoperative ... Meningioma | Continous infus... Single infusion Placebo | 18 Years - 65 Years | Beijing Tiantan Hospital | |
| Embolization for Meningioma | NCT05416567 | Meningioma | Endovascular em... | 18 Years - | St. Olavs Hospital | |
| Combination of Alpelisib and Trametinib in Progressive Refractory Meningiomas | NCT03631953 | Meningioma | Trametinib Alpelisib Blood sample MRI | 18 Years - | Assistance Publique Hopitaux De Marseille | |
| Molecular-Guided Therapy for Childhood Cancer | NCT02162732 | Neuroblastoma Medulloblastoma Glioma Ependymoma Choroid Plexus ... Craniopharyngio... Dysembryoplasti... Meningioma Primitive Neuro... Germ Cell Tumor... Rhabdomyosarcom... Non-rhabdomyosa... Ewings Sarcoma Osteosarcoma Wilms Tumor Renal Cell Carc... Malignant Rhabd... Clear Cell Sarc... Liver Tumors | Guided Therapy | 13 Months - 21 Years | Milton S. Hershey Medical Center | |
| Intraoperative Laser Speckle Contrast Imaging to Assess Blood Flow During Neurosurgery | NCT05028400 | Aneurysm AVM Dural Arteriove... Glioma Meningioma Metastasis | Laser speckle c... | 18 Years - | Insel Gruppe AG, University Hospital Bern | |
| Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma | NCT00589784 | CNS Cancer Meningioma Intracranial He... Hemangioblastom... Neurofibromatos... | Sunitinib | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma | NCT04305470 | Meningioma | Gleolan (Aminol... | 18 Years - | NX Development Corp | |
| Monthly SOM230C for Recurrent or Progressive Meningioma | NCT00859040 | Meningioma | SOM230C | 18 Years - | Dana-Farber Cancer Institute | |
| Information Presentation Formats | NCT02267928 | Meningioma | Check Symptoms Uncheck Symptom... Experienced Not Experienced | 18 Years - | Carnegie Mellon University | |
| Dexanabinol in Patients With Brain Cancer | NCT01654497 | Brain Cancer | Dexanabinol | 18 Years - | University of California, San Diego | |
| Cabozantinib for Patients With Recurrent or Progressive Meningioma | NCT05425004 | Meningioma | Cabozantinib | 18 Years - | Baptist Health South Florida | |
| T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer | NCT01967823 | Melanoma Meningioma Breast Cancer Non-Small Cell ... Hepatocellular ... | Anti-NY ESO-1 m... Cyclophosphamid... Fludarabine Aldesleukin | 15 Years - 70 Years | National Institutes of Health Clinical Center (CC) | |
| Tranexamic Acid Reduce Blood Loss in Meningioma Resection | NCT04386642 | Meningioma | Tranexamic acid Placebo | 18 Years - 60 Years | Chiang Mai University | |
| Research of Biomarkers of Response to Proton Beam Therapy in Pediatric and Adult Patients. | NCT04367779 | Brain Cancer Meningioma Sarcoma | - | Centre Leon Berard | ||
| Monthly SOM230C for Recurrent or Progressive Meningioma | NCT00859040 | Meningioma | SOM230C | 18 Years - | Dana-Farber Cancer Institute | |
| A Study of ONC201 for Refractory Meningioma | NCT06012929 | Meningioma Refractory Meni... Relapsed Mening... | ONC201 | 19 Years - | University of Nebraska | |
| Peptide Receptor Radionuclide Therapy Administered to Participants With Meningioma With 67Cu-SARTATE™ | NCT03936426 | Meningioma | Cu-64 SARTATE a... | 50 Years - | Clarity Pharmaceuticals Ltd | |
| Embolization for Meningioma | NCT05416567 | Meningioma | Endovascular em... | 18 Years - | St. Olavs Hospital | |
| Neurocognition After Radiotherapy in CNS- and Skull-base Tumors | NCT05727605 | Cognition Brain Tumor Magnetic Resona... Meningioma Glioma Pituitary Adeno... | Neurocognitive ... MRI Questionnaires:... Toxicity scorin... | 18 Years - | Universitaire Ziekenhuizen KU Leuven | |
| Automated Segmentation and Volumetry for Meningioma Using Deep Learning | NCT05093751 | Meningioma Artificial Inte... | Observation | 18 Years - | Seoul National University Hospital | |
| Natural History Study of Patients With Neurofibromatosis Type 2 | NCT00598351 | Neurofibromatos... | 8 Years - 75 Years | National Institutes of Health Clinical Center (CC) | ||
| Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC | NCT04298541 | Meningioma | Ga-68- DOTATATE Ga-68-DOTATOC | 18 Years - 89 Years | Weill Medical College of Cornell University | |
| Neurocognition After Radiotherapy in CNS- and Skull-base Tumors | NCT05727605 | Cognition Brain Tumor Magnetic Resona... Meningioma Glioma Pituitary Adeno... | Neurocognitive ... MRI Questionnaires:... Toxicity scorin... | 18 Years - | Universitaire Ziekenhuizen KU Leuven | |
| Antineoplaston Therapy in Treating Patients With Meningioma | NCT00003483 | Meningioma | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients | NCT02933736 | Glioblastoma Mu... Meningioma | Ribociclib | 18 Years - | St. Joseph's Hospital and Medical Center, Phoenix | |
| S9005 Mifepristone in Meningioma | NCT03015701 | Meningioma | Mifepristone Placebo | 18 Years - 120 Years | SWOG Cancer Research Network | |
| NF2 Natural History Consortium | NCT00004483 | Schwannoma, Ves... Neurofibromatos... Meningioma | 5 Years - | Office of Rare Diseases (ORD) | ||
| Phase II Study of SOM230 in Patients With Recurrent or Progressive Meningioma | NCT00813592 | Cancer | SOM230B | 18 Years - | University of Utah | |
| Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma | NCT06014905 | Meningioma | Hyperpolarized ... Magnetic Resona... Saline | 18 Years - | University of California, San Francisco | |
| Monthly SOM230C for Recurrent or Progressive Meningioma | NCT00859040 | Meningioma | SOM230C | 18 Years - | Dana-Farber Cancer Institute | |
| Meningiomas and Treatment With CYPROTERONE ACETATE or Progestin | NCT04109404 | Meningioma | 18 Years - | University Hospital, Brest | ||
| Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC) | NCT03273712 | Neuroendocrine ... Meningioma Neuroblastoma Medulloblastoma | 90Y-DOTA tyr3-O... 68Ga-DOTATOC PE... Amino Acids | 6 Months - 90 Years | University of Iowa | |
| Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology | NCT04648462 | Astrocytoma Ependymoma Ganglioglioma Oligodendroglio... Optic Nerve Gli... Meningioma Nerve Sheath Ne... Adenoma Craniopharyngio... Hemangiopericyt... Germinoma Neurilemmoma | ProTRAIT | 18 Years - | Maastricht Radiation Oncology | |
| Meningiomas and Treatment With CYPROTERONE ACETATE or Progestin | NCT04109404 | Meningioma | 18 Years - | University Hospital, Brest | ||
| Establishment and Characterization of Meningioma Patient-derived Organoids | NCT04478877 | Meningioma | 18 Years - | Chinese University of Hong Kong | ||
| Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors | NCT01324635 | Recurrent Gliom... High-grade Meni... Brain Metastasi... | Panobinostat Stereotactic bo... Quality-of-life... Stereotactic ra... | 18 Years - | Thomas Jefferson University | |
| 177Lu-DOTATATE for Recurrent Meningioma | NCT06326190 | Recurrent Menin... | Local standard ... 177Lu-DOTATATE | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory Meningioma | NCT03267836 | Meningioma Meningioma, Adu... | Avelumab Proton Therapy Surgery | 18 Years - | Washington University School of Medicine | |
| Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors | NCT03095248 | Neurofibromatos... Vestibular Schw... Meningioma Ependymoma Glioma | Selumetinib | 3 Years - 45 Years | Children's Hospital Medical Center, Cincinnati | |
| Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System | NCT04743310 | Central Nervous... | tozuleristide Canvas imaging ... Surgical resect... | 18 Years - | Cedars-Sinai Medical Center | |
| Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas | NCT03071874 | Meningioma | AZD2014 | 18 Years - | Massachusetts General Hospital | |
| Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors | NCT01324635 | Recurrent Gliom... High-grade Meni... Brain Metastasi... | Panobinostat Stereotactic bo... Quality-of-life... Stereotactic ra... | 18 Years - | Thomas Jefferson University | |
| Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma | NCT03971461 | Meningioma | Lutathera | 18 Years - | NYU Langone Health | |
| Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory Meningioma | NCT03267836 | Meningioma Meningioma, Adu... | Avelumab Proton Therapy Surgery | 18 Years - | Washington University School of Medicine | |
| Analysis of NF2 Mutations in Radiation-Related Neural Tumors | NCT00340496 | Neural Tumors | - | National Institutes of Health Clinical Center (CC) | ||
| Carbon Ion Radiotherapy for Atypical Meningiomas | NCT01166321 | Meningioma | Carbon Ion Radi... | 18 Years - | University Hospital Heidelberg | |
| AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas | NCT02831257 | Neurofibromatos... Meningioma | AZD2014 | 18 Years - | Massachusetts General Hospital | |
| Intravenous Tranexamic Acid Reducing Intraoperative Blood Loss in Huge Meningiomas Resection | NCT05230381 | Tranexamic Acid Intraoperative ... Meningioma | Continous infus... Single infusion Placebo | 18 Years - 65 Years | Beijing Tiantan Hospital | |
| Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas | NCT01966809 | Brain Tumor, Re... | Photofrin photo... | 18 Years - | Medical College of Wisconsin | |
| MiDura-Study (Neuro-Patch in Duraplasty) | NCT04189172 | Meningioma Tumor, Brain Chiari Malforma... Vascular Malfor... Hydrocephalus Tethered Cord Dural Fistula Craniotomy Spinal Surgery Duraplasty | 18 Years - | Aesculap AG | ||
| Combination of Hydroxyurea and Verapamil for Refractory Meningiomas | NCT00706810 | Cancer Brain Cancer Meningioma | Hydroxyurea Verapamil | 18 Years - | University of Utah | |
| Dose Response of Functionally Critical Brain Regions for Brain Radiotherapy | NCT01212237 | Brain Tumors | fMRI Evaluation | 18 Years - 80 Years | Weill Medical College of Cornell University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
